Acceleron Pharma Inc. (XLRN) — Analyst outlook / Analyst consensus target is. Based on 26 analyst ratings, the consensus is bullish — 18 Buy, 7 Hold, 1 Sell.
The consensus price target is $150.00 (low: $139.00, high: $160.00), representing a downside of 16.1% from the current price $178.75.
XLRN Stock — 12-Month Price Forecast
$150.00
▼ -16.08% Downside
Average Price Target
Based on 26 Wall Street analysts offering 12-month price targets for Acceleron Pharma Inc., the average price target is $150.00, with a high forecast of $160.00, and a low forecast of $139.00.
The average price target represents a -16.08% change from the last price of $178.75.
Highest Price Target
$160.00
Average Price Target
$150.00
Lowest Price Target
$139.00
XLRN Analyst Ratings
Buy
Based on 26 analysts giving stock ratings to Acceleron Pharma Inc. in the past 3 months
